Systemic Aspergillus presenting with visual symptoms.
Telander
David G
DG
Department of Ophthalmology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455-0501, USA.
Pambuccian
Stefan E
SE
Olsen
Timothy W
TW
D000368:Aged; D000900:Anti-Bacterial Agents; D001228:Aspergillosis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D015821:Eye Infections, Fungal / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D017809:Fatal Outcome; D005260:Female; D016469:Fungemia / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D014786:Vision Disorders / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D014822:Vitreous Body / Q000382:microbiology
D000900:Anti-Bacterial Agents